annual SGA:
$70.45M+$32.81M(+87.19%)Summary
- As of today (May 29, 2025), NAMS annual SGA is $70.45 million, with the most recent change of +$32.81 million (+87.19%) on December 31, 2024.
- During the last 3 years, NAMS annual SGA has risen by +$64.77 million (+1140.90%).
- NAMS annual SGA is now at all-time high.
Performance
NAMS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$27.15M+$2.84M(+11.69%)Summary
- As of today (May 29, 2025), NAMS quarterly SGA is $27.15 million, with the most recent change of +$2.84 million (+11.69%) on March 31, 2025.
- Over the past year, NAMS quarterly SGA has increased by +$12.70 million (+87.86%).
- NAMS quarterly SGA is now at all-time high.
Performance
NAMS quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$2.07B-$187.36M(-9.94%)Summary
- As of today (May 29, 2025), NAMS TTM SGA is -$2.07 billion, with the most recent change of -$187.36 million (-9.94%) on March 31, 2025.
- Over the past year, NAMS TTM SGA has dropped by -$2.12 billion (-4680.90%).
- NAMS TTM SGA is now -11080.63% below its all-time high of -$18.54 million.
Performance
NAMS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
NAMS Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +87.2% | +87.9% | -4680.9% |
| 3 y3 years | +1140.9% | - | - |
| 5 y5 years | +4549.0% | - | - |
NAMS Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1140.9% | at high | +325.9% | <-9999.0% | at low |
| 5 y | 5-year | at high | +4549.0% | at high | +325.9% | <-9999.0% | at low |
| alltime | all time | at high | +4549.0% | at high | +325.9% | <-9999.0% | at low |
NAMS Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $27.15M(+11.7%) | $84.04M(+17.8%) |
| Dec 2024 | $70.45M(+87.2%) | $24.31M(+40.7%) | $71.34M(+12.2%) |
| Sep 2024 | - | $17.28M(+12.9%) | $63.60M(+17.4%) |
| Jun 2024 | - | $15.30M(+5.8%) | $54.17M(+19.7%) |
| Mar 2024 | - | $14.45M(-12.8%) | $45.25M(+20.2%) |
| Dec 2023 | $37.63M | $16.57M(+111.0%) | $37.63M(+78.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $7.85M(+23.2%) | $21.07M(+59.4%) |
| Jun 2023 | - | $6.38M(-6.8%) | $13.21M(+93.2%) |
| Mar 2023 | - | $6.84M | $6.84M |
| Dec 2022 | $19.51M(+243.6%) | - | - |
| Dec 2021 | $5.68M(+274.6%) | - | - |
| Dec 2020 | $1.52M | - | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual SGA?
- What is the all time high annual SGA for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual SGA year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly SGA?
- What is the all time high quarterly SGA for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly SGA year-on-year change?
- What is NewAmsterdam Pharma Company NV TTM SGA?
- What is the all time high TTM SGA for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV TTM SGA year-on-year change?
What is NewAmsterdam Pharma Company NV annual SGA?
The current annual SGA of NAMS is $70.45M
What is the all time high annual SGA for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual SGA is $70.45M
What is NewAmsterdam Pharma Company NV annual SGA year-on-year change?
Over the past year, NAMS annual SGA has changed by +$32.81M (+87.19%)
What is NewAmsterdam Pharma Company NV quarterly SGA?
The current quarterly SGA of NAMS is $27.15M
What is the all time high quarterly SGA for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly SGA is $27.15M
What is NewAmsterdam Pharma Company NV quarterly SGA year-on-year change?
Over the past year, NAMS quarterly SGA has changed by +$12.70M (+87.86%)
What is NewAmsterdam Pharma Company NV TTM SGA?
The current TTM SGA of NAMS is -$2.07B
What is the all time high TTM SGA for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high TTM SGA is -$18.54M
What is NewAmsterdam Pharma Company NV TTM SGA year-on-year change?
Over the past year, NAMS TTM SGA has changed by -$2.12B (-4680.90%)